Text Size
8 studies found for:    primatene

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Safety Study in Adolescent and Adult Patients With Asthma
Condition: Asthma
Interventions: Drug: Placebo;   Drug: Primatene Mist;   Drug: Epinephrine inhalation aerosol, HFA;   Drug: epinephrine inhalation aerosol
2 Completed Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
Condition: Asthma
Interventions: Drug: Epinephrine inhalation aerosol;   Drug: Placebo;   Drug: epinephrine inhalation aerosol
3 Completed
Has Results 		Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
Condition: Asthma
Intervention: Drug: epinephrine inhalation aerosol
4 Terminated Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
Condition: Asthma
Interventions: Drug: E004 (epinephrine inhalation aerosol), 90 mcg/actuation;   Drug: E004 Placebo;   Drug: E004 (epinephrine inhalation aerosol), 125 mcg;   Drug: E004 (epinephrine inhalation aerosol), 220 mcg;   Drug: epinephrine inhalation aerosol, CFC propelled;   Drug: E004 (epinephrine inhalation aerosol), 160 mcg
5 Completed Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS
Condition: Asthma
Interventions: Drug: Treatment arm T1;   Drug: Treatment arm T2;   Drug: Treatment arm C
6 Terminated Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
Condition: Asthma
Interventions: Drug: Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation;   Drug: Arm C-Epinephrine Inhalation Aerosol CFC
7 Completed
Has Results 		Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Conditions: Asthma;   Bronchospasm;   Wheezing;   Shortness of Breath
Interventions: Drug: Epinephrine Inhalation Aerosol, HFA;   Drug: Epinephrine Inhalation Aerosol
8 Completed Assessment of Airway Obstruction in Infants With Lower Respiratory Infections
Conditions: Bronchiolitis;   Respiratory Syncytial Virus Infections
Intervention: Drug: Inhaled primatene will be given as a breathing treatment
To Top

† Indicates status has not been verified in more than two years